Arimidex in McCune Albright Syndrome

Clinical trial NCT00055302 · COMPLETED

Trial details

NCT number: NCT00055302
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

McCune-Albright Syndrome

Start date: 2002-08-01
Primary completion: 2006-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.